Completed Pilot Trial: Mobile App uMAT-R Shows Promise for Pregnant Women with Opioid Use Disorder — Digital Therapeutics Evidence Emerges

References

1. 1.Baumel, A., Muench, F., Edan, S., & Kane, J. M. (2017). Objective user engagement with mental health apps: systematic search and panel-based usage analysis. Journal of Medical Internet Research, 19(9), e7594. https://doi.org/10.2196/jmir.7594
2. 2.Haight, S. C., Ko, J. Y., Tong, V. T., Bohm, M. K., & Callaghan, W. M. (2018). Opioid use disorder documented at delivery hospitalization—United States, 1999–2014. Morbidity and Mortality Weekly Report, 67(31), 845-849. https://doi.org/10.15585/mmwr.mm6731a1
3. 3.Jones, H. E., Kaltenbach, K., Heil, S. H., Stine, S. M., Coyle, M. G., Arria, A. M., O'Grady, K. E., Selby, P., Martin, P. R., & Fischer, G. (2010). Neonatal abstinence syndrome after methadone or buprenorphine exposure. New England Journal of Medicine, 363(24), 2320-2331. https://doi.org/10.1056/NEJMoa1005359
4. 4.Krans, E. E., & Patrick, S. W. (2016). Opioid use disorder in pregnancy: health policy and practice in the midst of an epidemic. Obstetrics & Gynecology, 128(1), 4-10. https://doi.org/10.1097/AOG.0000000000001446
5. 5.Schiff, D. M., Nielsen, T., Terplan, M., Hood, M., Bernson, D., Diop, H., Bharel, M., Wilens, T. E., LaRochelle, M., Walley, A. Y., & Land, T. (2018). Fatal and nonfatal overdose among pregnant and postpartum women in Massachusetts. Obstetrics & Gynecology, 132(2), 466-474. https://doi.org/10.1097/AOG.0000000000002734
6. 6.Washington University School of Medicine. (2024). mHealth to Help Pregnant and Postpartum Women in Recovery for Opioid Use Disorder. ClinicalTrials.gov. NCT06701123. https://clinicaltrials.gov/study/NCT06701123